[GLUTAMIC-OXALACETIC TRANSAMINASE AND GLUTAMIC-PYRUVIC TRANSAMINASE IN ATHLETES SUBJECTED TO ANTITETANUS VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE. I]